We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Ipca Laboratories UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.
Information on taking, submitting and processing samples which potentially contain MPXV.
This series brings together all documents relating to drugs licensing.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
Explains changes to drug driving law and the guidance available for healthcare professionals and users of prescription medicine.
Guidance on using non-investigational medicinal products in a clinical trial.
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).